Non-alcoholic fatty liver disease and sarcopenia additively increase mortality: a Korean nationwide survey

被引:35
作者
Moon, Joon Ho [1 ]
Koo, Bo Kyung [1 ,2 ]
Kim, Won [1 ,3 ]
机构
[1] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea
[2] Seoul Metropolitan Govt, Boramae Med Ctr, Dept Internal Med, Div Endocrinol & Metab, Seoul, South Korea
[3] Seoul Metropolitan Govt, Boramae Med Ctr, Dept Internal Med, Div Gastroenterol & Hepatol, Seoul, South Korea
基金
新加坡国家研究基金会;
关键词
Non-alcoholic fatty liver disease; Sarcopenia; Mortality; Nationwide survey; FIBROSIS STAGE; ASSOCIATION; DIAGNOSIS; RISK; MANAGEMENT; AGE; INFLAMMATION; FEATURES; OUTCOMES;
D O I
10.1002/jcsm.12719
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Background Sarcopenia is an independent risk factor not only for advanced-stage non-alcoholic fatty liver disease (NAFLD) but also for mortality. We investigated the association of sarcopenia and/or NAFLD with mortality among the Korean general population. Methods Individuals aged 35-75 years without any history of cancer, ischaemic heart disease, ischaemic stroke, or secondary causes of chronic liver disease were selected from the Korean National Health and Nutrition Examination Surveys from 2008 to 2015. Their mortality data until December 2018 were retrieved from the National Death Registry. NAFLD and sarcopenia were defined by hepatic steatosis index and appendicular skeletal muscle mass divided by body mass index (BMI), respectively. Results A total of 28 060 subjects were analysed [mean age, 50.6 (standard error, 0.1) years, 48.2 (0.3) % men]; the median follow-up duration was of 6.8 (interquartile range, 4.8, 8.4) years. NAFLD predicted mortality after adjustment for age, sex, BMI, hypertension, dyslipidaemia, and smoking (HR 1.32, 95% CI 1.03-1.70), but this prediction lost its statistical significance after additional adjustment for diabetes mellitus. In contrast, NAFLD with advanced fibrosis independently increased the risk of mortality after adjustment for all covariates (HR 1.68, 95% CI 1.02-2.79). Stratified analysis revealed that NAFLD and sarcopenia additively increased the risk of mortality as an ordinal scale (HR 1.46, 95% CI 1.18-1.81, P for trend = 0.001). The coexistence of NAFLD and sarcopenia increased the risk of mortality by almost twice as much, even after adjustment for advanced fibrosis (HR 2.18, 95% CI 1.38-3.44). Conclusions Concurrent NAFLD and sarcopenia conferred a two-fold higher risk of mortality. The observation that NAFLD and sarcopenia additively increase mortality suggests that risk stratification would be helpful in predicting mortality among those with metabolic derangement.
引用
收藏
页码:964 / 972
页数:9
相关论文
共 50 条
  • [31] Clinically Meaningful Fatigue and Depression Are Associated with Sarcopenia in Patients with Non-Alcoholic Fatty Liver Disease
    Sheptulina, Anna F.
    Yafarova, Adel A.
    Golubeva, Julia A.
    Mamutova, Elvira M.
    Kiselev, Anton R.
    Drapkina, Oxana M.
    JOURNAL OF PERSONALIZED MEDICINE, 2023, 13 (06):
  • [32] Effects of sleep quality on non-alcoholic fatty liver disease: a cross-sectional survey
    Takahashi, Atsushi
    Anzai, Yukio
    Kuroda, Masahito
    Kokubun, Masae
    Kondo, Yuichiro
    Ogata, Takashi
    Fujita, Masashi
    Hayashi, Manabu
    Imaizumi, Hiromichi
    Abe, Kazumichi
    Tanji, Nobuo
    Ohira, Hiromasa
    BMJ OPEN, 2020, 10 (10):
  • [33] Myosteatosis rather than sarcopenia associates with non-alcoholic steatohepatitis in non-alcoholic fatty liver disease preclinical models
    Nachit, Maxime
    De Rudder, Maxime
    Thissen, Jean-Paul
    Schakman, Olivier
    Bouzin, Caroline
    Horsmans, Yves
    Vande Velde, Greetje
    Leclercq, Isabelle Anne
    JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 2021, 12 (01) : 144 - 158
  • [34] THE ROLE OF BLOOD GROUPS IN NON-ALCOHOLIC FATTY LIVER DISEASE AND NON-ALCOHOLIC STEATOHEPATITIS
    Karagoz, Hatice
    Erden, Abdulsamet
    Ozer, Ozerhan
    Cetinkaya, Ali
    Avci, Deniz
    Gencer, Vedat
    Arik, Ferhat
    Kalan, Ugur
    Gorkem, Hasan
    Karaman, Hatice
    Karaman, Ahmet
    ACTA MEDICA MEDITERRANEA, 2017, 33 (02): : 205 - 210
  • [35] Muscle strength and non-alcoholic fatty liver disease/metabolic-associated fatty liver disease
    Hao, Xuan-Yu
    Zhang, Kai
    Huang, Xing-Yong
    Yang, Fei
    Sun, Si-Yu
    WORLD JOURNAL OF GASTROENTEROLOGY, 2024, 30 (07) : 636 - 643
  • [36] The Association between Liver Enzymes and Mortality Stratified by Non-Alcoholic Fatty Liver Disease: An Analysis of NHANES III
    Grob, Saskia Rita
    Suter, Flurina
    Katzke, Verena
    Rohrmann, Sabine
    NUTRIENTS, 2023, 15 (13)
  • [37] Non-alcoholic fatty liver disease-related fibrosis and sarcopenia: An altered liver-muscle crosstalk leading to increased mortality risk
    Kuchay, Mohammad Shafi
    Martinez-Montoro, Jose Ignacio
    Kaur, Parjeet
    Fernandez-Garcia, Jose Carlos
    Gurugram, Bruno Ramos-Molina Medicity Hospital
    AGEING RESEARCH REVIEWS, 2022, 80
  • [38] Relationship of sarcopenia with steatohepatitis and advanced liver fibrosis in non-alcoholic fatty liver disease: a meta-analysis
    Yu, Rui
    Shi, Qiangwei
    Liu, Lei
    Chen, Lidong
    BMC GASTROENTEROLOGY, 2018, 18
  • [39] Age-dependent effects of diabetes and obesity on liver-related events in non-alcoholic fatty liver disease: Subanalysis of CLIONE in Asia
    Seko, Yuya
    Kawanaka, Miwa
    Fujii, Hideki
    Iwaki, Michihiro
    Hayashi, Hideki
    Toyoda, Hidenori
    Oeda, Satoshi
    Hyogo, Hideyuki
    Morishita, Asahiro
    Munekage, Kensuke
    Kawata, Kazuhito
    Yamamura, Sakura
    Sawada, Koji
    Maeshiro, Tatsuji
    Tobita, Hiroshi
    Yoshida, Yuichi
    Naito, Masafumi
    Araki, Asuka
    Arakaki, Shingo
    Kawaguchi, Takumi
    Noritake, Hidenao
    Ono, Masafumi
    Masaki, Tsutomu
    Yasuda, Satoshi
    Tomita, Eiichi
    Yoneda, Masato
    Tokushige, Akihiro
    Kamada, Yoshihiro
    Takahashi, Hirokazu
    Ueda, Shinichiro
    Aishima, Shinichi
    Sumida, Yoshio
    Okanoue, Takeshi
    Itoh, Yoshito
    Nakajima, Atsushi
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2022, 37 (12) : 2313 - 2320
  • [40] Sarcopenia is associated with advanced liver fibrosis in patients with non-alcoholic fatty liver disease.
    Kang, Min Kyu
    Park, Jung Gil
    Kim, Min Cheol
    Lee, Heon Ju
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 : 421 - 421